Pomalid - Pomalidomide 2mg 21 Capsules (Pomalyst) - Anticancer Medication

POMALIDOMIDE 2 mg (Pomalid) x 21 Capsules

Name: POMALIDOMIDE 2 mg Capsule
Brand: Natco Pharma Ltd
SKU: pomalid2
Price: 140.00 USD
Availability: InStock

~~$300.00~~ $140.00

Prescription Required

Pomalid contains Pomalidomide 2 mg, an immunomodulatory drug used in the treatment of multiple myeloma (a type of blood cancer), especially in patients who have not responded to other therapies such as lenalidomide and bortezomib.

Generic Name	Pomalidomide
Manufacturer	Natco Pharma Ltd
Packing	21 Capsules in 1 Bottle
Prescribed For	Multiple Myeloma
Availability	In Stock
Shipping to	USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

POMALIDOMIDE 2 mg Price in Different Currencies

Package	USD	GBP	AUD	NZD	PHP	KRW	RON	HKD	MYR	THB	AED
21 Capsules	$140	£104	A$196	NZ$243	₱8,782	₩191,498	lei 643	HK$1,098	RM565	฿4,655	د.إ514

Benefits of POMALIDOMIDE 2 mg

Helps treat multiple myeloma in patients requiring advanced therapy
Supports slowing the growth and spread of cancer cells
May improve treatment response when combined with other cancer medicines
Assists in managing relapsed or refractory multiple myeloma
Supports the immune system in targeting abnormal cells
Used under medical supervision as part of targeted cancer treatment

Side Effects

Fatigue or weakness
Nausea or vomiting
Constipation or diarrhea
Dizziness
Back pain or muscle pain
Fever
Low appetite
Shortness of breath
Swelling of hands or feet
Cough

Pomalidomide Price and Reimbursement Information by Country

Pomalidomide prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.

View Pomalidomide medicinal-form and pricing information on NICE BNF (UK) – https://bnf.nice.org.uk/drugs/pomalidomide-specialist-drug/medicinal-forms/
View Pomalidomide pricing information on Drugs.com (USA) – https://www.drugs.com/price-guide/pomalidomide
View Pomalidomide pricing and subsidy information on PBS (Australia) – https://www.pbs.gov.au/medicine/item/12665N-12661J
View Pomalidomide subsidy and medicine information on the National Drug Formulary (Singapore) – https://www.ndf.gov.sg/about-drugs/active-ingredient/m01336/
View Pomalyst (pomalidomide) reimbursement review information from CDA-AMC (Canada) – https://www.cda-amc.ca/pomalyst-multiple-myeloma-details

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.